21 May 2013
Keywords: kos, files, niaspan, uk, pharmaceuticals, usa, filed
Article | 16 July 1998
Kos Pharmaceuticals of the USA has filed for approval to marketNiaspan, its proprietary extended-release formulation of the
lipid-lowering drug niacin, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
28 April 1998
4 December 1998
20 May 2013
© 2013 thepharmaletter.com